Retirement Systems of Alabama cut its stake in DaVita Inc. (NYSE:DVA – Free Report) by 11.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,084 shares of the company’s stock after selling 1,329 shares during the quarter. Retirement Systems of Alabama’s holdings in DaVita were worth $1,653,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Transcendent Capital Group LLC acquired a new position in DaVita in the 3rd quarter worth about $25,000. Blue Trust Inc. grew its stake in shares of DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in DaVita in the second quarter worth approximately $43,000. Quarry LP bought a new position in DaVita during the third quarter valued at approximately $60,000. Finally, Point72 Hong Kong Ltd acquired a new stake in DaVita in the second quarter valued at approximately $68,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the stock. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. Barclays raised their target price on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $161.80.
DaVita Stock Performance
NYSE:DVA opened at $151.85 on Friday. The firm has a market capitalization of $12.45 billion, a PE ratio of 16.38, a PEG ratio of 0.86 and a beta of 0.90. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. DaVita Inc. has a 1 year low of $103.40 and a 1 year high of $169.51. The firm’s fifty day simple moving average is $157.18 and its 200 day simple moving average is $150.83.
DaVita (NYSE:DVA – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the firm posted $2.85 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, sell-side analysts anticipate that DaVita Inc. will post 9.71 EPS for the current year.
DaVita Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Stories
- Five stocks we like better than DaVita
- Canadian Penny Stocks: Can They Make You Rich?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- How to buy stock: A step-by-step guide for beginners
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.